289 related articles for article (PubMed ID: 32653467)
61. Use of macrolides in lung diseases: recent literature controversies.
Silva Filho LV; Pinto LA; Stein RT
J Pediatr (Rio J); 2015; 91(6 Suppl 1):S52-60. PubMed ID: 26354869
[TBL] [Abstract][Full Text] [Related]
62. Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index.
Terlizzi V; Castellani C; Taccetti G; Ferrari B
Ital J Pediatr; 2022 Aug; 48(1):141. PubMed ID: 35927765
[TBL] [Abstract][Full Text] [Related]
63. Aerosolized deoxyribonuclease for cystic fibrosis.
Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672
[No Abstract] [Full Text] [Related]
64. Mucolytic therapy in cystic fibrosis.
Wallis C
J R Soc Med; 2001; 94 Suppl 40(Suppl 40):17-24. PubMed ID: 11601159
[No Abstract] [Full Text] [Related]
65. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
[TBL] [Abstract][Full Text] [Related]
66. Deoxyribonuclease for cystic fibrosis.
Kearney CE; Wallis CE
Cochrane Database Syst Rev; 2000; (2):CD001127. PubMed ID: 10796748
[TBL] [Abstract][Full Text] [Related]
67. Recombinant human deoxyribonuclease for cystic fibrosis.
Jones AP; Wallis CE
Cochrane Database Syst Rev; 2003; (3):CD001127. PubMed ID: 12917899
[TBL] [Abstract][Full Text] [Related]
68. Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.
Snijders D; Calgaro S; Bertozzi I; Quartesan S; Kozuh I; Lunardi F; Barbato A
Int J Immunopathol Pharmacol; 2013; 26(2):529-34. PubMed ID: 23755770
[TBL] [Abstract][Full Text] [Related]
69. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.
Cimmino M; Nardone M; Cavaliere M; Plantulli A; Sepe A; Esposito V; Mazzarella G; Raia V
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1097-101. PubMed ID: 16365224
[TBL] [Abstract][Full Text] [Related]
70. Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis.
Bryson HM; Sorkin EM
Drugs; 1994 Dec; 48(6):894-906. PubMed ID: 7533697
[TBL] [Abstract][Full Text] [Related]
71. Bronchiectasis.
Magis-Escurra C; Reijers MH
BMJ Clin Evid; 2015 Feb; 2015():. PubMed ID: 25715965
[TBL] [Abstract][Full Text] [Related]
72. Dornase alfa: a new option in the management of cystic fibrosis.
Witt DM; Anderson L
Pharmacotherapy; 1996; 16(1):40-8. PubMed ID: 8700791
[TBL] [Abstract][Full Text] [Related]
73. The role of dornase alfa in the treatment of cystic fibrosis.
Cramer GW; Bosso JA
Ann Pharmacother; 1996 Jun; 30(6):656-61. PubMed ID: 8792953
[TBL] [Abstract][Full Text] [Related]
74. Dornase alfa improves the health-related quality of life among Brazilian patients with cystic fibrosis--a one-year prospective study.
Rozov T; de Oliveira VZ; Santana MA; Adde FV; Mendes RH; Paschoal IA; Caldeira Reis FJ; Higa LY; Toledo AC; Pahl M;
Pediatr Pulmonol; 2010 Sep; 45(9):874-82. PubMed ID: 20583292
[TBL] [Abstract][Full Text] [Related]
75. Mucoactive drugs.
Balsamo R; Lanata L; Egan CG
Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
[TBL] [Abstract][Full Text] [Related]
76. [2 significant stages in the management of mucoviscidosis: the French experience with dornase alfa (Pulmozyme) and the impact in international registries].
Brémont F; Navarro J
Arch Pediatr; 1998 Apr; 5(4):367-70. PubMed ID: 9759154
[No Abstract] [Full Text] [Related]
77. Consensus conference: practical applications of Pulmozyme. September 22, 1993.
Ramsey BW; Dorkin HL
Pediatr Pulmonol; 1994 Jun; 17(6):404-8. PubMed ID: 8090614
[No Abstract] [Full Text] [Related]
78. rhDNase in cystic fibrosis.
Tyrrell JC; Lewis PA; Sheldon CD; Connett G
Thorax; 1999 Aug; 54(8):752. PubMed ID: 10490419
[No Abstract] [Full Text] [Related]
79. [Inhaled bronchodilators and mucolytic agents in cystic fibrosis].
Le Roux P; Le Luyer B
Arch Pediatr; 2003 Sep; 10 Suppl 2():358s-363s. PubMed ID: 14671935
[TBL] [Abstract][Full Text] [Related]
80. Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction.
Daviskas E; Robinson M; Anderson SD; Bye PT
J Aerosol Med; 2002; 15(3):331-41. PubMed ID: 12396422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
